Gilead’s Marketing Application Validated by EMA; Accenture Misses Zack’s Consensus Estimate

Accenture plc (NYSE:ACN - News) – For an in-depth report on Accenture plc follow: www.BullTrends.com/stockquote/ACN

CAN shares closed down 5.03% on nearly 15 million shares traded. The stock was one of the biggest decliners on the NYSE. The company reported second-quarter fiscal 2014 earnings per share of $1.03 which missed the Zacks Consensus Estimate of $1.04. On a year-over-year basis earnings increased 3%. Year-ago quarter’s earnings excluded benefits from certain U.S. federal tax liabilities and reorganization benefits.

Gilead Sciences Inc. (NASDAQ:GILD - News) - For an in-depth report on Gilead Sciences Inc. follow: www.BullTrends.com/stockquote/GILD

Shares of Gilead Sciences closed down 1.88% on about 17.7 million shares traded. The stock was one of the most active stocks on the NASDAQ. Gilead announced that the company’s Marketing Authorization Application,MAA, for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir, LDV, 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir, SOF, 400 mg for the treatment of chronic hepatitis C virus, HCV, genotype 1 infection, has been fully validated and is now under assessment by the European Medicines Agency, EMA.

Quasar Aerospace Industries, Inc. (OTC:QASP - News) - For an in-depth report on Quasar Aerospace Industries, Inc. follow: www.BullTrends.com/stockquote/QASP

Shares of QASP closed up 28.57% on Thursday with about 950 million shares traded. The stock had one of the biggest volume jumps in the OTC market and was one of the biggest advancers. The company announced that its President, Donnell J. Vigil, will be heading to Colorado next week to conduct business. Mrs. Vigil plans to meet face to face with her contacts and intends to further pursue other opportunities in the MJ market. Quasar realizes the various aspects of the MJ industry and is aiming to explore all avenues to secure the most profitability sector as possible. Those avenues include the hemp industry, the MMJ market and the retail store fronts.

TriNet Group, Inc. (NYSE:TNET - News) - For an in-depth report on TriNet Group, Inc. follow: www.BullTrends.com/stockquote/TNET

Shares of TNET closed up 19.38% on Thursday making it one of the biggest winners on the NYSE. The stock traded around 14.2 million shares. It was the first day of trading after the cloud-based payroll processing company's IPO. The company priced its initial public offering at $16, the midpoint of its expected range of $15 to $17. This values the company at approximately $1.09 billion. TriNet sold 15 million shares to raise $240 million.

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.